A novel inhibitor of monooxygenase reversed the activity of tetracyclines against tet(X3)/tet(X4)-positive bacteria

BACKGROUND: Tigecycline is one of the few last-resort antibiotics for the treatment of carbapenem-resistant Enterobacteriaceae infection, the incidence of which has been rapidly increasing. However, the emergence and spread of tigecycline resistance genes tet(X) (including tet(X3) and tet(X4)) has l...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Zhou, Yonglin, Niu, Sen, Liu, Zhiying, Zou, Yinuo, Yang, Yanan, Feng, Haihua, Liu, Dejun, Niu, Xiaodi, Deng, Xuming, Wang, Yang, Wang, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933826/
https://www.ncbi.nlm.nih.gov/pubmed/35306337
http://dx.doi.org/10.1016/j.ebiom.2022.103943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933826/
https://www.ncbi.nlm.nih.gov/pubmed/35306337
http://dx.doi.org/10.1016/j.ebiom.2022.103943

Ejemplares similares